tradingkey.logo

Clearpoint Neuro Inc

CLPT
14.110USD
+0.650+4.83%
收盤 02/09, 16:00美東報價延遲15分鐘
14.27M總市值
虧損本益比TTM

Clearpoint Neuro Inc

14.110
+0.650+4.83%

關於 Clearpoint Neuro Inc 公司

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Clearpoint Neuro Inc簡介

公司代碼CLPT
公司名稱Clearpoint Neuro Inc
上市日期Jul 03, 2019
CEOBurnett (Joseph Michael)
員工數量115
證券類型Ordinary Share
年結日Jul 03
公司地址120 S. Sierra Avenue
城市SOLANA BEACH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編92075
電話19499006833
網址https://www.clearpointneuro.com/
公司代碼CLPT
上市日期Jul 03, 2019
CEOBurnett (Joseph Michael)

Clearpoint Neuro Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.33K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
79.75K
+884.00%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+21093.00%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.47K
+386.00%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-10200.00%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.33K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
79.75K
+884.00%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+21093.00%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.47K
+386.00%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-10200.00%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Products: Functional neurosurgery
3.42M
38.62%
Services: Biologics and drug delivery
3.11M
35.10%
Products: Biologics and drug delivery
1.29M
14.58%
Product Systems and software products
647.00K
7.30%
Services: Capital equipment and other
390.00K
4.40%
地區USD
名稱
營收
佔比
United States
8.86M
100.00%
業務
地區
業務USD
名稱
營收
佔比
Products: Functional neurosurgery
3.42M
38.62%
Services: Biologics and drug delivery
3.11M
35.10%
Products: Biologics and drug delivery
1.29M
14.58%
Product Systems and software products
647.00K
7.30%
Services: Capital equipment and other
390.00K
4.40%

股東統計

更新時間: 2月6日 週五
更新時間: 2月6日 週五
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
5.94%
BlackRock Institutional Trust Company, N.A.
5.47%
Bigger Capital Funds, LP
4.48%
PTC Therapeutics Inc
3.01%
Geode Capital Management, L.L.C.
2.21%
其他
78.90%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
5.94%
BlackRock Institutional Trust Company, N.A.
5.47%
Bigger Capital Funds, LP
4.48%
PTC Therapeutics Inc
3.01%
Geode Capital Management, L.L.C.
2.21%
其他
78.90%
股東類型
持股股東
佔比
Investment Advisor
21.26%
Investment Advisor/Hedge Fund
10.48%
Hedge Fund
8.69%
Individual Investor
4.99%
Corporation
3.01%
Research Firm
1.38%
Bank and Trust
0.10%
Pension Fund
0.03%
Insurance Company
0.03%
其他
50.03%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
245
12.49M
41.97%
-295.70K
2025Q3
241
11.91M
44.93%
+805.07K
2025Q2
228
11.11M
37.29%
+1.29M
2025Q1
216
9.82M
36.04%
-268.85K
2024Q4
204
9.20M
33.04%
+1.04M
2024Q3
190
8.15M
32.05%
-235.56K
2024Q2
185
8.39M
33.08%
-454.38K
2024Q1
183
8.85M
30.95%
+359.48K
2023Q4
183
7.82M
35.41%
+717.11K
2023Q3
184
7.11M
35.71%
+336.40K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
1.50M
5.03%
+22.52K
+1.53%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.63M
5.47%
+127.17K
+8.48%
Sep 30, 2025
Bigger Capital Funds, LP
1.29M
4.34%
+126.00K
+10.80%
Sep 30, 2025
PTC Therapeutics Inc
894.58K
3.01%
--
--
Aug 23, 2024
Geode Capital Management, L.L.C.
656.40K
2.21%
+31.60K
+5.06%
Sep 30, 2025
State Street Investment Management (US)
482.65K
1.62%
+149.27K
+44.77%
Sep 30, 2025
Two Sigma Investments, LP
442.93K
1.49%
+421.00K
+1919.91%
Sep 30, 2025
Bigger (Michael)
378.69K
1.27%
--
--
Sep 30, 2025
UBS Financial Services, Inc.
360.70K
1.21%
+205.29K
+132.10%
Sep 30, 2025
District 2 Capital LP
307.75K
1.03%
-122.42K
-28.46%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
1.19%
iShares Neuroscience and Healthcare ETF
0.94%
iShares Micro-Cap ETF
0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
Vanguard US Momentum Factor ETF
0.06%
Motley Fool Next Index ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比1.19%
iShares Neuroscience and Healthcare ETF
佔比0.94%
iShares Micro-Cap ETF
佔比0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.09%
Vanguard US Momentum Factor ETF
佔比0.06%
Motley Fool Next Index ETF
佔比0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.03%
iShares Russell 2000 Growth ETF
佔比0.03%
iShares Russell 2000 ETF
佔比0.02%
Proshares Ultra Russell 2000
佔比0.02%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI